Sellas Life Financials

SLS Stock  USD 1.20  0.01  0.83%   
Based on the measurements of operating efficiency obtained from Sellas Life's historical financial statements, Sellas Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
  
Please note, the imprecision that can be found in Sellas Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sellas Life Sciences. Check Sellas Life's Beneish M Score to see the likelihood of Sellas Life's management manipulating its earnings.

Sellas Life Stock Summary

Sellas Life competes with NLS Pharmaceutics, Mereo BioPharma, Day One, Eyenovia, and Cognition Therapeutics. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company was founded in 2012 and is headquartered in New York, New York. Sellas Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS81642T2096
CUSIP363256108 81642T209 363256504 81642T100 74978T109
LocationNew York; U.S.A
Business AddressTimes Square Tower,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.sellaslifesciences.com
Phone646 200 5278
CurrencyUSD - US Dollar

Sellas Life Key Financial Ratios

Sellas Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sellas Life's current stock value. Our valuation model uses many indicators to compare Sellas Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sellas Life competition to find correlations between indicators driving Sellas Life's intrinsic value. More Info.
Sellas Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Sellas Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Sellas Life Sciences Systematic Risk

Sellas Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sellas Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Sellas Life Sciences correlated with the market. If Beta is less than 0 Sellas Life generally moves in the opposite direction as compared to the market. If Sellas Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sellas Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sellas Life is generally in the same direction as the market. If Beta > 1 Sellas Life moves generally in the same direction as, but more than the movement of the benchmark.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Sellas Life is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Sellas has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Sellas Life's financials are consistent with your investment objective using the following steps:
  • Review Sellas Life's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Sellas Life's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Sellas Life's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Sellas Life's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Sellas Life Thematic Clasifications

Sellas Life Sciences is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
BiotechView
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas

Sellas Life March 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Sellas Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sellas Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sellas Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Sellas Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sellas Life's daily price indicators and compare them against related drivers.

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.